Welcome to Hylife Biotech Pty Ltd
The Cell and Gene Catalyst in Australia aims to establish a comprehensive, high-quality value chain capable of discovering, developing, producing, and delivering cell and gene therapies to patients within the country. Simultaneously, it strives to generate employment, commercialize research findings, and export Australian therapies internationally.
Read More
Information regarding biopharmaceuticals, biologics, biosimilars, personalized medicine, stem cell therapies, and regenerative medicine.
Read More
AusMedtech, affiliated with Hylife Biotech, serves as the leading industry association for the medical devices and diagnostics sector in Australia.
Read More
The following resources are designed to assist life sciences boards in adhering to best practices, regulations, and corporate governance guidelines.
Read More
As the Australian regenerative medicine (RM) industry gears up for a period of growth and prosperity, Hylife Biotech takes the helm of a consortium consisting of seven partners, with the aim of delivering significant benefits to both the Australian economy and the health of its citizens.
Read More
Clinical trials are poised to have a central role in the forthcoming economy, which will depend significantly on innovative employment, exports, and productivity.
Read MoreSign up to stay up to date with upcoming Hylife Biotech events
